Pancreatic Cancer Research

ResearcherUniversitair Ziekenhuis LeuvenActive in the last 2 years

Gregory Sergeant

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8846-3824; OpenAlex author ID A5059175776. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 4

  1. The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study. Co-author DOI 10.1016/j.annonc.2024.12.015↗
  2. Extended lymphadenectomy in patients with pancreatic cancer is debatable. Co-author DOI 10.1007/s00268-013-2064-z↗
  3. Pancreatic cancer circulating tumour cells express a cell motility gene signature that predicts survival after surgery. Co-author DOI 10.1186/1471-2407-12-527↗
  4. Perioperative cancer cell dissemination detected with a real-time RT-PCR assay for EpCAM is not associated with worse prognosis in pancreatic ductal adenocarci… Co-author DOI 10.1186/1471-2407-11-47↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Baki Topal · 2 shared papers, 2011–2012 · strength 0.07
  2. Michelle Lucinda DeOliveira · 1 shared paper, 2013 · strength 0.05
  3. Pierre‐Alain Clavien · 1 shared paper, 2013 · strength 0.05
  4. Mickaël Lesurtel · 1 shared paper, 2013 · strength 0.05
  5. Jos F. van Pelt · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.